Replimune

Developer of oncolytic immunotherapies

placeOxford, England, United Kingdom calendar_todayFounded 2015 groups152 employees language replimune.com

Registered entities

Social engagement

Social engagement: 20.5K social following, 8 posts in the last 12 months — below the industry typical range.

Investor mix

9 investors on record; lead investors include Foresite Capital.

Investor typeCountShare
Venture capital556%
Bank & private debt222%
Other / undisclosed222%

Hiring activity

No recent openings observed

No roles tracked in the last 12 months

3 Jul 2025 · Sr. Manager, Global Regulatory Publishing · Woburn

7 Dec 2024 · Director, Medical Writing · Woburn

Based on job postings tracked across public sources.

Recent activity

20 Oct 2025
Milestone
regulatory
Coming soon